Re-Engaging Individuals & Societies for Structural Evolution: A Brain Health Equity Neuropsychology Research Framework
Archives of Clinical Neuropsychology · 2023
DOI: 10.1093/arclin/acad011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Clinical Neuropsychology, 2023. Verfasst von Mirella Díaz-Santos und 4 weiteren Autor:innen. Beteiligte Einrichtung: Mary S. Easton Center for Alzheimer's Disease Research, UCLA Department of Neurology, Los Angeles, CA 90095, USA. Hauptthemen laut MEDLINE: Health Equity. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 168 Literaturangaben.
Abstract (Originalsprache)
Objective
A brain health equity neuropsychology research framework (NRF) is crucial to the anti-racist movement in cognitive assessments. Universalist interpretation of neuropsychological tools contributes to systemic disparities, and there is a need for a clear conceptual framework for disentangling the direct and indirect impact of social determinants of health (SDH) on brain-behavior relationships and neuropsychological performance. The aim of this paper is to present a NRF anchored in the principles of brain health and health equity that is inclusive, and can be implemented across racially and ethnically diverse communities.
Methods
The Re-engaging Individuals and societies for Structural Evolution (RISE) NRF aims to address this via a two-pronged approach: 1. Focusing on community engagement and recruitment and retention of individuals and societies typically not equitably represented in brain health studies, and 2. Integrating the conceptual structure of individual, community, and SDH, while considering the broader historical and current structures that differentially shape these.
Results
The proposed RISE NRF is dynamic and multidirectional. It identifies barriers and proposes strategies to engage communities and diversify recruitment. It identifies evidence-based guidance on non-cognitive determinants of health to include, consider or explore in brain health research.
Conclusion
The RISE NRF can guide the development of culturally and linguistically responsive methodologies and assist with clearly conceptualized and contextualized interpretation of neuropsychological tools to foment a transformative science that benefits the brain health of marginalized communities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Mary S. Easton Center for Alzheimer's Disease Research, UCLA Department of Neurology, Los Angeles, CA 90095, USA.
- Center for Cognitive Neuroscience, UCLA Department of Psychiatry & Biobehavioral Sciences, Los Angeles, CA 90095, USA.
- Department of Neurology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
- Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
- Department of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA.
- Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA.
ORCID-Profile: David Andrés González, Adriana Macias Strutt
Zitieren
APA
Díaz-Santos, M., González, D. A., Henry, S. K., Vuong, K. D., & Strutt, A. M. (2023). Re-Engaging Individuals & Societies for Structural Evolution: A Brain Health Equity Neuropsychology Research Framework. Archives of Clinical Neuropsychology. https://doi.org/10.1093/arclin/acad011
Vancouver
Díaz-Santos M, González DA, Henry SK, Vuong KD, Strutt AM. Re-Engaging Individuals & Societies for Structural Evolution: A Brain Health Equity Neuropsychology Research Framework. Archives of Clinical Neuropsychology. 2023. doi:10.1093/arclin/acad011
BibTeX
@article{DazSantos2023,
author = {Díaz-Santos, Mirella and González, David Andrés and Henry, Samantha K and Vuong, Kevin Dat and Strutt, Adriana Macias},
title = {Re-Engaging Individuals & Societies for Structural Evolution: A Brain Health Equity Neuropsychology Research Framework},
journal = {Archives of Clinical Neuropsychology},
year = {2023},
doi = {10.1093/arclin/acad011}
}
EUVIMED